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SUMMARY 
 Vibrio parahaemolyticus is an emerging enteric pathogen. The O3:K6 serotype 
has become pandemic, and the genome has been sequenced for one strain of this serotype 
(20).  The thermostabile direct hemolysin (tdh), thermostabile related hemolysin (trh), 
and two distinct Type III Secretion Systems (T3SS) have been implicated in virulence. 
T3SSs secrete their own virulence proteins called effectors, and the hemolysins are 
secreted independently of the T3SS.  Deletion studies have determined that the T3SS 
alone are sufficient to induce eukaryotic cell apoptosis.  The T3SS loci are found within 
two separate genomic islands.  Because genomic islands are known to be disseminated by 
Lateral Gene Transfer (LGT), we examined the distribution of the pandemic genomic 
island genes among clinical and environmental V. parahaemolyticus isolates and also 
among closely-related environmental Vibrio spp. using primers designed to amplify 
hemolysins and T3SS effectors previously characterized for V. parahaemolyticus strain 
RIMD2210633 (23). We also examined the distribution of a hypothetical bacteriocin, 
encoded by vpa1263, within another genomic island that is similar to the bacteriocins 
produced by Escherichia coli.  Preliminary screens for the bacteriocin gene suggest that 
many clinical strains and some environmental strains contain vpa1263.  PCR screens for 
the T3SS effector genes have shown that 22% of closely-related environmental Vibrio 
spp. contain at least one T3SS1 or one T3SS2 effector gene.  Strains selected as closely-
related environmental Vibrio spp. for this analysis were identified as yellow sucrose-
fermenting colonies on the selective Thiosulfate Citrate Bile Salts Sucrose (TCBS) agar, 
while environmental isolates of V. parahaemolyticus were identified as green colonies on 
TCBS.  Because PCR screens have detected the presence of the V. parahaemolyticus 
 xi 
thermolabile hemolysin (tl) within strains that grew yellow on TCBS, we may have 
overestimated the distribution of T3SS effector genes.  Alternately, the Vibrio 
parahaemolyticus tl gene could be transferred to closely-related species, or V. 
parahaemolyticus may have aquired the ability to ferment sucrose.  While sequencing of 
the effector genes and the housekeeping gene recA are ongoing, preliminary results 
suggest that the tl positive isolates that grow yellow on TCBS, may actually be V. 
parahaemolyticus.  Since V. parahaemolyticus may have acquired the ability to ferment 
sucrose, the TCBS plating method may not be conclusive enough for the separation of 
Vibrio spp.
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CHAPTER 1 
INTRODUCTION 
 
 
1.1 Vibrio parahaemolyticus: an emerging pathogen 
Vibrio parahaemolyticus is an emerging enteric pathogen that was first discovered 
in Japan in 1950 as the cause of a food poisoning outbreak (14).  This Gram-negative 
marine bacterium is now the major cause of seafood borne gastroenteritis within the 
United States and the major cause of all foodborne infections in Asian countries (14). 
Although humans mainly become infected with the bacterium by consuming raw or 
undercooked shellfish, septicemia can also result from wound infections (14, 26). 
Nevertheless, infections are thought to be underreported (6).  Prior to 1996, pathogenic 
strains exhibited diverse serotypes; however, since this time, the O3:K6 serotype and 
related strains have become pandemic (14).  As a result of the pathogen’s emergence, the 
genome has been sequenced for the RIMD2210633 strain of the O3:K6 serotype.  Two 
virulence genes have been previously identified from V. parahaemolyticus pathogenic 
strains.  These genes include the thermostable direct hemolysin (tdh) and the tdh-related 
hemolysin (trh) (26).  More recently, the Type III Secretion System (T3SS) effector 
genes have been shown to contribute to the virulence mechanism of V. parahaemolyticus 
(3, 14, 25, 26) .  Although the presence of hemolysins has been used as an indicator of the 
pathogenicity of clinical isolates, hemolysin-deficient strains have recently been shown to 
be pathogenic (26).  The indication that screening for hemolysins alone may 
underestimate pathogens has spurred further research of the T3SSs.  While researching 
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the function of potential virulence genes will benefit the medical community in 
diagnosing and treating infections, few studies have examined the role these genes play in 
the emergence of the pathogen.  Epidemics of V. parahaemolyticus infection have 
become more frequent and more globally distributed within the last 10 years (14); 
however, the pathogen’s emergence remains to be elucidated.   
To address the pathogen’s emergence, Hurley et al. 2006 examined the 
distribution of T3SS effector genes between pathogenic clinical and non-pathogenic 
environmental V. parahaemolyticus samples collected over several years (14), but these 
researchers have not sequenced the effector genes to determine their diversity within the 
species.  This study examined the genomic island distribution primarily among clinical V. 
parahaemolyticus strains.  To date, there have been no studies that have analyzed the 
sequence diversity of the T3SS effector genes between the pathogenic and the non-
pathogenic environmental isolates.  Furthermore, studying only V. parahaemolyticus 
isolates without examining other species of Vibrio from the same niche (14) may 
underestimate the reservoir of virulence genes.  This is because the Lateral Gene Transfer 
(LGT) of pandemic V. parahaemolyticus virulence genes to non-V. parahaemolyticus 
strains or vice versa will affect the distribution of the genes.  The distribution of V. 
parahaemolyticus virulence genes by LGT was briefly assessed (26) in the study by Park 
et al, but the researchers used a hybridization technique that was too stringent to detect 
nucleotide substitutions.  They showed that T3SS genes were present in V. alginolyticus, 
V. harveyi, and V. tubiashii strains (26); however, no studies to date have examined 
whether co-occurring non-V. parahaemolyticus strains in the environment may serve as a 
reservoir for T3SS genes.  Therefore, we propose that a polymerase chain reaction (PCR) 
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screen for the pandemic virulence genes and subsequent gene sequencing may be more 
appropriate for examining virulence gene distribution by LGT. 
LGT can also disseminate large gene clusters called genomic islands.  Seven 
genomic islands have been identified within the RIMD2210633 genome and are denoted 
as VPaI-1 through VPaI-7 (14).  Because the hemolysins and two T3SS gene clusters are 
located within the genomic islands VPa-1 and VPaI-7, we hypothesized that the virulence 
genes undergo LGT and that this may explain the pathogen’s emergence. We have 
previous evidence to support this hypothesis based on the identification of a genomic 
island gene on the plasmid of an environmental V. parahaemolyticus isolate.  This gene is 
a putative bacteriocin and will be discussed in Chapter 2. Briefly, the gene was isolated 
from the environmental V. parahaemolyticus 22702 strain, and it was 96% identical to 
the vpa1263 gene found within VPaI-6 of the pandemic O3:K6 serotype.  Thus more 
broadly, we hypothesize that pandemic V. parahaemolyticus genomic island genes, which 
include the hemolysins, the T3SSs, and the putative bacteriocin will be present in 
environmental V. parahaemolyticus and other co-occurring Vibrio species (Figure 1.1). 
To more accurately determine the size of the potential V. parahaemolyticus 
virulence gene reservoir, we will: 
1. Examine the distribution of T3SS effector protein-encoding genes and 
hemolysin genes in V. parahaemolyticus environmental isolates and other 
co-occurring Vibrio species. 
2. Determine the sequence diversity of T3SS effector protein-encoding genes 
to examine the evolution of these genes and the emergence of the 
pathogen. 
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Figure 1.1 Lateral Gene Transfer of V. parahaemolyticus genomic island genes. V. 
parahaemolyticus strain RIMD2210633 contains 7 genomic islands. VpaI-1, VpaI-6, and 
VpaI-7 are shown. VpaI-1 encodes a T3SS1 injectisome and its associated effector 
proteins VP1680 and VP1686. VpaI-7 encodes the T3SS2 injectisome, the T3SS2 
translocator protein VPA1354, the T3SS2 effector proteins VPA1346 and VPA1362, and 
two copies of Tdh. The environmental strain of V. parahaemolyticus 22702 contains a 
plasmid encoding vpa1263. Our study will examine whether the bacteriocin gene and the 
T3SS effector genes, and hemolysin genes undergo lateral gene transfer. 
 
 
1.2 Vibrio parahaemolyticus virulence genes 
The most well-studied V. parahaemolyticus virulence genes are the hemolysins 
(23). These include the thermostable direct hemolysin (tdh) and the thermostable direct-
related hemolysin (trh) (23).  The proteins encoded by these genes were named 
hemolysins due to their ability to lyse erythrocytes. Hemolysins contribute to lysis by 
forming pores in bacterial membranes, which modifies the ion balance (5). Typically, 
only 1-6% of V. parahaemolyticus strains in the environment have been shown to have 
either tdh or trh (18).  Expression of either gene results in the β- type hemolysis observed 
Wagatsuma agar, which is known as the Kanagawa Phenomenon (KP).  The KP detection 
Vibrio parahaemolyticus 
O3:K6 strain RIMD2210633 
Vibrio parahaemolyticus  
22702 
DNA LGT ? 
T3SS1 Bacteriocin gene 
vpa1263 T3SS2 and tdh 
VpaI-1 VpaI-6 VpaI-7
Genomic Islands 
Environmental Bacteria 
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assay has served as the clinical confirmation of pathogenicity (26).  Because the 
observation of KP is time consuming and some clinical strains have been isolated that 
lack tdh and are KP negative (2), the following alternative in vitro diagnostic measures 
have emerged: immunological techniques employing monoclonal antibodies specific for 
hemolysins (2), multiplex PCR reactions to amplify hemolysin genes (2), and pulsed-
field gel electrophoresis (PFGE) of restriction endonuclease sites (21, 26).  Nevertheless, 
observation of KP and serotyping remains standard in identifying V. parahaemolyticus 
pathogenic strains.  The thermostabile direct hemolysin related gene, trh, was examined 
in multiple Vibrio spp., and was observed in Vibrio alginolyticus (12).  One recent study 
showed that tdh can be spontaneously deleted due to its association with insertion 
sequences, which suggests that rearrangement and LGT of tdh may be occurring (16). 
After the RIMD2210633 strain had its genome sequenced, two additional 
virulence mechanisms were discovered.  These include two distinct Type III Secretion 
Systems (T3SS) known as T3SS1 and T3SS2.  To date there have been no studies that 
have examined the reservoir of T3SS genes in environmental Vibrio populations. 
 
1.3 Bacterial Secretion Systems 
 Currently, six bacterial secretion systems have been identified (30).The secretion 
system basal components are structurally similar to flagellum basal body (8).  Gram-
positive bacteria tend to secrete extracellular proteins via a general secretion pathway, but 
because Gram negative bacteria contain a periplasmic space and an outer membrane, they 
often possess specialized secretion systems (28).  Both the T3SS and the type 4 secretion 
system (T4SS) have been identified in V. parahaemolyticus and are involved with 
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virulence and injection of effector proteins into the cytosol of a host cell (4, 8).  The 
T4SS is found in Helicobacter pylori, Legionella pneumophila and Bordetella pertussis 
(4, 28).  Secretion systems have been found on pathogenicity islands (28). Recently, a 
Type 6 Secretion System was reported in Vibrio parahaemolyticus, and it was predicted 
to have homology to a strain of V. harveyi (5), that we used as an outgroup in our gene 
trees in this study. 
 
1.3.1 Type III Secretion Systems 
 Several Gram-negative bacteria including Shigella spp., and Salmonella spp. (20), 
enteropathogenic and enterohemorrhagic Escherichia coli, Yersinia spp., and 
Pseudomonas spp. contain complex T3SS (4).  The T3SS apparatus, or injectisome (7), is 
essentially a small needle comprised of about 20 proteins (3, 25) that pierces the cell 
membrane of a eukaryotic cell and injects effector molecules into the host cell cytosol. 
T3SS structures are highly conserved between bacteria while the effectors are more 
variable (25). Once the effectors are injected into eukaryotes they often target the 
cytoskeleton (4, 6) and disrupt signaling pathways (3).  One pathway that is often 
disrupted is the NFκB (4).  For example, the Vibrio parahaemolyticus T3SS1 effector 
VP1686 has been shown to result in apoptosis through the inhibiton of NFκB (3). 
 7 
1.4 Bacteriocins 
  Bacteriocins are protein antimicrobials secreted by bacteria that typically inhibit 
closely related bacterial species (1, 31) by either forming pores in the cytoplasmic 
membranes, non-specifically degrading nucleic acids, cleaving 16S rRNA or tRNA, or 
inhibiting peptidoglycan synthesis (1).  Often, bacteria that produce bacteriocins contain 
immunity proteins to protect themselves from their own bacteriocin (1, 31).  The protein 
domains of a bacteriocin can be separated based on local function (1).  It is believed that 
bacteriocins result in enhanced fitness for a cell through the competitive inhibition of 
bacteria that share the same niche (1, 31).  Bacteriocins have been identified from both 
Gram-negative and Gram-positive bacteria. The bacteriocins produced by Escherichia 
coli are referred to as colicins (27). Vibrio cholerae (27), Vibrio Vulnificus (27, 29), and 
Vibrio harveyi (27) each have their own bacteriocins.  Research with the mucosal 
pathogen Streptococcus pneumoniae shows a competitive advantage for bacteriocin 
production in the nasopharynx (31), while studies show colicin producing E. coli can gain 
a competitive advantage in the intestines (17) 
  Currently, the Food and Drug Administration agency of the USDA has approved 
the bacteriocin nisin for use in agricultural products.  Nisin is produced by Lactobacilus 
lactis (1, 10), but because bacteriocins must be over-expressed and purified in bulk to be 
practical for the agricultural industry as topical antimicrobials, several companies have 
begun using live cultures of commensal bacteria in their products (24).  This practice is 
termed probiotics and occurs naturally in dairy products (24), particularly yogurt. 
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1.5 Lateral Gene Transfer 
  The transfer of genetic material between an organism or cell and its offspring is 
considered vertical gene transfer.  In contrast, Lateral Gene Transfer (LGT) is the transfer 
of genetic material between different species (32).Genetic material that is disseminated 
by LGT is often transferred via Mobile Genetic Elements (MGEs) (11). MGEs include 
bacteriophages, plasmids, transposons, and insertion sequences (Figure 1.2). Abnormal 
GC nucleotide content of a gene or genomic island relative to a genome is often used to 
determine whether LGT has occurred (15). 
 
Figure 1.2 Lateral Gene Transfer. Bacteria can acquire novel genetic material from the 
environment by transformation (a), directly from another bacterium by conjugation (b), 
or through viral nucleic acid integration and subsequent transduction (c). 
 
1.6 Genomic Islands 
 Genomic islands are large regions of the genome characteristically flanked by 
direct repeats and either integrase or transposase genes, which suggests the distribution of 
genomic islands is mediated by MGEs (14).  MGEs can contribute to the evolution of 
bacterial pathogenicity by transferring virulence genes.  For example, cholera toxin 
deficient strains of V. cholerae that express the toxin co-regulated pilus (TCP) can 
acquire the ctxAB cholera toxin genes from the CTXΦ phage and become pathogenic 
(34). Likewise, pathogenicity can be imparted following the acquisition of a 
a
b
c
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pathogenicity island, which is simply a genomic island carrying one or more virulence 
genes.  The RIMD2210633 strain is proposed to have increased virulence due to the 
presence of predicted pathogenicity islands (14). 
 
1.7 Genomic Islands of V. parahaemolyticus 
 Seven genomic islands were identified in V. parahaemolyticus and are denoted 
VPaI-1 through VPaI-7 (14).  Virulence genes were identified on the predicted 10-kb 
pathogenicity island VPaI-1 and the 81-kb region VPaI-7.  The T3SS1 gene cluster is 
located within VPaI-1 on chromosome I, and the T3SS2 gene cluster is located within 
VPaI-7 on chromosome 2. T3SS2 was present in all pandemic strains analyzed (23), and 
T3SS1 was found in all V. parahaemolyticus isolates examined.  In addition to the T3SS2 
gene cluster, VpaI-7 (23) also carries two copies of the thermostable direct hemolysin 
(tdh) gene (23).  Since LGT can disseminate genes carried within genomic islands, we 
studied the distribution and diversity of the T3SS effector genes and the hemolysin genes,  
A separate genomic island identified among V. parahaemolyticus pandemic 
strains, VPaI-6, contains the gene vpa1263, which is a putative bacteriocin gene (14).  
This gene is homologous to the colicins of Escherchia coli.  Since LGT can disseminate 
genes carried within genomic islands, we also studied the distribution of the hypothetical 
bacteriocin gene. 
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CHAPTER 2 
VIBRIO PARAHAEMOLYTICUS PUTATIVE BACTERIOCIN 
 
2.1 The putative V. parahaemolyticus bacteriocin gene vpa1263 
 The V. parahaemolyticus O3:K6 serotype strain RIMD2210633 contains the gene 
vpa1263 within the VpaI-6 genomic island.  This gene shares a conserved domain with 
the colicins of Escherichia coli and s-type pyocins of Streptococcus spp.  We 
hypothesized that the hypothetical protein encoded by this gene is a bacteriocin that 
inhibits growth of V. parahaemolyticus and related Vibrio spp. To determine whether the 
bacteriocin is functional, we used the flip-agar technique previously developed to screen 
for bacteriocinogenic activity of Vibrio. harveyi (22).  vpa1263 is the first bacteriocin-
like gene to be reported for V. parahaemolyticus.  
 
2.2 Experimental design for bacteriocin function 
  We used the flip-agar technique to determine whether any strains were 
bacteriocinogenic. In this method, a 10ul sample of 1x 109 cells/ml culture of 
RIMD2210633 was spotted on the agar and incubated at 30˚C for 24 hours.  After 
incubation, the agar was inverted into the lid of the Petri dish and an indicator strain was 
plated on the newly exposed agar at approximately 107 cells/ml. In this assay bacteriocins 
that are produced would have diffused through the media during the overnight incubation 
and inhibit the growth of indicator strains.   
 To ensure that bacteriocin production is due to vpa1263, we are currently 
conducting a gene deletion to assess whether bacteriocin production is abolished in its 
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absence.  The deletion is based on homologous recombination of the flanking regions of a 
fusion product of the vpa1263 gene.  We designed primers to amplify flanking regions of 
the vpa1263 gene then fused them together. Using restriction digests and ligations we 
constructed a suicide vector containing the flanking DNA regions (Figure 2.1).  This 
vector was then used to force the vpa1263 gene from the bacterial chromosome by 
homologous recombination with the flanking regions (Figure 2.1).  Due to the size of the 
gene and the occurrence of spontaneous mutations in the sacB gene of the suicide vector, 
we have had difficulty obtaining colonies that have undergone homologous 
recombination and loss of the suicide vector.  Spontaneous mutations in sacB eliminate 
the sucrose sensitivity counter-selection required for loss of the suicide vector.  We are 
investigating whether we can use an alternate vector that does not rely on sucrose 
sensitivity for loss of the vector and completion of the gene deletion. 
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Figure 2.1. Vector construction for vpa1263 deletion. DNA flanking the bacteriocin was 
amplified separately using primers D1, D2, and D3, D4 respectively.  The D1/D2 
amplicon and the D3/D4 amplicon were then fused together using the external D1 and D4 
primers. Fusion was possible because the D2 and D3 primers were designed with 
homologous ends.  The resulting amplicon and the suicide vector pko2.0 were separately 
double digested with the same restriction enzymes ApaI and SacI / XhoI.  The digested 
amplicon was then inserted into the vector. The resulting vector was then electroporated 
into electrocompetent E. coli cells and white colonies were selected as successful 
transformations. 
 
2.3 Distribution of vpa1263 
  Additionally, we discovered that the plasmid p22702B, isolated from the V. 
parahaemolyticus strain 22702, contains a gene with 96% homology to the vpa1263 gene 
found in RIMD2210633.  Because the RIMD2210633 vpa1263 gene is located within the 
genomic island VPaI-6, we further hypothesized that the gene may be undergoing LGT 
 13 
mediated by MGEs.  To determine whether the gene occurs more frequently in 
environmental populations independent of the pandemic VPaI-6 genomic island, we 
decided to collect environmental samples and use polymerase chain reaction (PCR) 
(Figure 2.2) to detect the presence of the gene. 
5’ Reverse primer 
5’
5’3’
3’…
Polymerase Chain Reaction
dATPForward primer 
Target gene
Taq polymerase
….…
.…
5’ dGTP
 
Figure 2.2. PCR annealing step. 
 
2.4 Experimental design to determine vpa1263 distribution 
 We collected sediment and water samples from marshes located at Skidaway Island 
GA, North Inlet, NC, and Apalachicola, FL in September 2006 and 2007.  Thiosulfate 
Citrate Bile Salts Sucrose (TCBS) agar (Difco), was prepared to culture the bacteria and 
identify Vibrio spp.  The sucrose in the green TCBS media is not fermented by V. 
parahaemolyticus and the colony remains green.  Other Vibrio species, such as Vibrio 
cholerae and Vibrio alginolyticus, appear yellow following the fermentation of 
sucrose(13).  It should be noted that Vibrio vulnificus also appears green on TCBS (13), 
and further identification through Major Locus Sequencing Typing (MLST) of conserved 
housekeeping genes is often necessary to determine whether green colonies on TCBS are 
indeed V. parahemolyticus.  We isolated presumptive V. parahaemolyticus green colonies 
and the yellow co-occurring Vibrio species and extracted their DNA by boiling a colony 
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with nuclease free water.  To screen for the presence of vpa1263 in our isolates we 
designed the following forward and reverse primers.  
   Forward 5’- GCTCTGCTTAGTTACAACGACCCA -3’   
   Reverse 5’- ATTTGGGAAGGTATTGGAGCACCC -3’  
 These primers yield an amplicon of 2126-bp, and were designed using the Primer3 
website and purchased from Integrated DNA Technologies (IDT).  Additionally, we used 
the IDT OligoAnalyzer internet feature to design primers that are unlikely to form 
homodimers, heterodimers, or hairpins, which would decrease the efficiency of the 
amplification. We used Polymerase Chain Reaction (PCR) to amplify presumptive 
vpa1263 genes to detectable concentrations from our isolates in a thermocycler.  PCR 
reagents were purchased from New England Biolabs. The final volume of the PCR 
reaction was 20ul with the final concentrations: 0.5uM for vpa1263 forward and reverse 
primers, 1Xbuffer, 0.02 U/ul taq polymerase, 2.5mM MgCl2, and 0.5mM dNTPs.  The 
following PCR cycle conditions were used: an initial denaturation step at 98°C for 2 
minutes, 35 cycles of (denaturation at 98°C for 15 seconds, annealing at 58°C for 30 
seconds, and elongation at 72°C for 1 minute), and a final elongation at 72°C for 5 
minutes.  The PCR amplicons were separated by size using agarose gel electrophoresis 
and were visualized via the incorporation of Ethidium Bromide and viewed under UV 
with a gel doc.  Bands were compared to a 2-log ladder.  
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2.5 Results for bacteriocin function 
 Bacteriocin production by the RIMD2210633 strain was observed with fine-
texture Acros agar (Figure 2.3), as shown by the zones of inhibition within the indicator 
growth, but was not observed with the coarse Difco agar.  This suggests that the 
bacteriocin’s activity is limited by diffusion. Table 2.1 shows that RIMD2210633 
inhibited 44% of V. parahaemolyticus clinical isolates and 39% of V. parahaemolyticus 
environmental isolates.  Bacteriocin production from RIMD2210633 did not inhibit the 
more distantly related species of V. harveyi and V. fischeri. RIMD2210633 was able to 
inhibit itself when grown as both a producer and an indicator.  
  Preliminary data suggests that deletion of the quorum-sensing regulator opaR 
resulted in a loss of the inhibitory activity (data not shown).  Further experiments are 
necessary to confirm the role of quorum-sensing for regulation of bacteriocin production.  
 
 
Figure 2.3. Flip agar bacteriocin screening assay.  Zones of clearing surrounding 
RIMD221063 show the inhibition of an environmental indicator strain.  
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Table 2.1. Summary of Bacteriocin Activity 
Strains Activity (mm)
No. inhibited 
(%)
Environmental V. parahaemolyticus ++++ 7/18 (39)
Clinical V. parahaemolyticus ++++ 7/16 (44)
V. harveyi - 0/1
V. fischeri - 0/1
 
* Vp clinical strains isolated from patients include RIM2210633 and 25 V. 
parahaemolyticus strains from the CDC. Environmental isolates were taken from 
marshes located at Skidaway Island Georgia, North Carolina, and Florida in 2006 and 
2007. 
 
2.6 Results for the distribution of vpa1263 
 To determine whether the putative bacteriocin gene vpa1263 may be undergoing 
LGT, we examined the distribution of vpa1263 within clinical and environmental isolates 
(Table 2.2).  We also examined the distribution of an adjacent gene on VpaI-6, vpa1260, 
to assess whether vpa1263 is likely to be present on the genomic island or if it may be 
independent of VpaI-6. In 60 environmental isolates examined, we found that 17% 
contained vpa1260 alone, 30% contained vpa1263 alone, and 17% contained both 
vpa1263 and vpa1260.  All nine O3:K6 clinical isolates examined were double positive 
for vpa1260 and vpa1263, while only 27% of non-O3:K6 clinical isolates were positive 
for both genes.  Environmental isolates have a higher frequency of vpa1260 alone and 
vpa1263 alone than either the O3:K6 clinical strains or non-O3:K6 clinical strains, while 
the clinical isolates have a higher incidence for both genes.  A greater percentage of 
environmental isolates contain vpa1263 (47%) relative to non-O3:K6 clinical strains 
(34%). 
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Table 2.2. Frequency of vpa1263 and the VPaI-6 gene vpa1260 
Strain Source No. vpa1260 only vpa1263  only vpa1260 and 
vpa1263
Environmentals 60 4 (17) 7 (30) 4 (17)
Clinicals O3:K6 9 - - 9 (100)
Clinicals non-O3:K6 30 3 (10) 2 (7) 8 (27)
Frequency (%)
 
* Vp clinical strains isolated from patients include RIM2210633 and 25 V. 
parahaemolyticus strains from the CDC.  Environmental isolates were taken from 
marshes located at Skidaway Island Georgia, North Carolina, and Florida in 2006 and 
2007. 
 
2.7 Discussion 
 The flip agar method shows that V. parahaemolyticus strain RIMD2210633 
produces a bacteriocin-like inhibitory substance (Figure 2.3) that can inhibit the growth 
of both clinical and environmental strains of V. parahaemolyticus, but is unable to inhibit 
V. haveryi or V. fischeri.  This may indicate that the V. parahaemolyticus bacteriocin has 
a narrow range of inhibition; however, because we only examined two other species 
(Table 2.1), bacteriocin screening with a larger sample of other Vibrio species is 
necessary to determine an inhibitory spectrum.  To confirm that vpa1263 is responsible 
for bacteriocin production, the generation of a deletion mutant is ongoing; nevertheless, a 
deletion in opaR showed loss of inhibitory activity.  Because the opaR deletion strain 
showed diminished bacteriocin production, we suspect that bacteriocin production 
may be regulated by quorum sensing; however, further experiments are required to 
confirm the role of quorum-sensing. 
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 Expression analysis with RT-PCR through varying stages of the growth cycle 
may provide insight into circumstances that lead to bacteriocin production.  If these 
studies suggest that vpa1263 is expressed in greater concentrations at higher cell 
densities, then there may be a selective advantage for producing the bacteriocin at the 
population level even without immunity proteins.  
The gene distribution for vpa1260 and vpa1263 within environmental isolates 
shows that vpa1260 is present in environmental isolates just as frequently by itself as it is 
to be found with vpa1263 (Table 2.2).  This finding may indicate that vpa1260 is just as 
likely to be independent of VpaI-6 as it is to be found within the genomic island.  
Because the percentage of environmental strains that contain vpa1263 alone (30%) is 
greater than the percentage with both vpa1263 and vpa1260 (17%), this may suggest that 
vpa1263 is more likely to be found independent of VpaI-6 than within the genomic 
island.  Alternately, these findings may indicate that either the vpa1263 primers anneal 
with greater efficiency, or vpa1260 may have greater sequence diversity than vpa1263.  
Our result that fewer non-O3:K6 isolates (27%) are positive for both vpa1263 and 
vpa1260 than the O3:K6 strains (100%) is in concordance with prior studies that suggest 
the O3:K6 serotype and other pandemic isolates have a higher incidence of genomic 
island genes, such as the T3SS2 gene cluster.  Interestingly, environmental isolates seem 
to be more likely to contain vpa1263 than non-O3:K6 clinical strains. This finding may 
relate to the fact that bacteriocins are generally active only against closely related strains. 
Since V. parahaemolyticus is a marine bacterium it is more likely to encounter similar 
strains in the ocean than in the gastrointestinal tract. The O3:K6 serotype may be more 
likely to contain the bacteriocin gene than environmental isolates simply because it is 
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more likely to contain the genomic island, or because a pandemic strain has more 
opportunity to associate with other environmental isolates and acquire genes.  Regardless 
of where the gene originated, the bacteriocin may be indirectly involved with 
pathogenicity by increasing the fitness of the O3:K6 serotype in the environment or 
within the intestines where the bacteriocin may increase fitness for the bacterium relative 
to non-pathogenic commensal bacteria.  
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CHAPTER 3 
VIBRIO PARAHAEMOLYTICUS TYPE III SECRETION SYSTEM 
  
 
3.1 Vibrio parahaemolyticus Type III Secretion System 
 Following the genome sequencing of RIMD2210633, the type III secretion 
system (T3SS) was proposed as an additional virulence mechanism to explain the 
occurrence of KP negative pathogens (23, 26).  The T3SS apparatus, or injectisome (7), is 
essentially a small needle comprised of about 20 proteins (3) that pierces the cell 
membrane of a eukaryotic cell and injects effector molecules into the host cell cytosol 
where they disrupt signaling pathways (3, 7).  T3SS structures are highly conserved 
between bacteria while the effectors are more variable (3, 7, 23, 26)  
 Unlike many other bacterial species, V. parahaemolyticus has been shown to 
possess two distinct T3SSs (3, 7, 23, 26).   
 
3.1.1 Vibrio parahaemolyticus T3SS1 
 The T3SS1 gene cluster is located on chromosome I, (14, 23).  The T3SS1 
apparatus resembles that of Yersinia spp. (3, 26), but there is no similarity between the 
Yersinia effectors and those of V. parahaemolyticus.  All V. parahaemolyticus strains 
examined have the T3SS1 (26) and the GC content of the loci is within range of the 
45.4% GC content of the genome (20). One of the T3SS1 apparatus genes examined in 
this study is vp1670 (23). 
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3.1.2 Vibrio parahaemolyticus T332 
 The T3SS2 gene cluster is located on chromosome II, within the 80-kb genomic 
island VpaI-7. The GC content of the T3SS2 loci is 39.8% (5, 20), which is suggestive of 
LGT.  Although the T3SS2 cluster appeared to be unique to V. parahaemolyticus KP+ 
strains (26), it has since been shown that non-O1, non-O139 V. cholerae strains also have 
the T3SS2 cluster (9, 23), which is also suggests LGT of VpaI-7. One of the T3SS2 
translocator genes examined in this study is vpa1354. 
 
3.2 Vibrio parahaemolyticus T3SS effector molecules 
 V. parahaemolyticus effector molecules show little similarity to other known 
proteins and the extent of the diversity of the V. parahaemolyticus T3SS effectors is not 
known (3, 26).  One study showed the secretion of four T3SS1 dependent effector 
proteins by 2D gel electrophoresis (25)  Deletion of vp1680 was demonstrated to reduce 
cytotoxicity to HeLa cells (25, 26) Furthermore, a mechanism describing another T3SS1 
effector protein, VP1686, was shown to induce apoptosis through inhibition of the NFκB 
transcription factor in macrophage populations (3).  In a separate study, cell death was 
due to autophagy (6). Although, the T3SS2 effector knock-out strains were not cytotoxic 
to HeLa cells, they appeared to be enterotoxic in a rabbit ileal loop test (25, 26).  Another 
study confirms that the T3SS2 non-O1 V. cholerae strain colonized infant mouse 
intestines and caused diarrhea and death in rabbits (9).  More functional studies must be 
undertaken to assign phenotypes to the twelve hypothetical proteins found within the 
T3SS1 (26) and the hypothetical proteins of T3SS2.  Additionally, related species should 
be examined for the same genes to determine if LGT is occurring between species. 
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3.3 Experimental Design 
 Environmental samples were collected from marshes at Skidaway, GA and 
Apalachicola, FL and were spread on TCBS plates. We isolated Vibrio parahaemolyticus 
green colonies and the yellow co-occurring Vibrio species by patching to M10 media.  
Colonies were grown overnight in M10 broth and stored at -80˚C.  The DNA templates 
for PCR were made by extracting their DNA by boiling a colony resuspended in nuclease 
free water.  Primers located in table 3.1 were developed in a previous study (23).  These 
primers were used for the initial screen to determine the distribution of T3SS effector 
genes in our samples.  PCR reagents were obtained from New England Biolabs.  The 
concentrations and cycle conditions were the same as in section 2.4.  Amplicons were 
applied to a 0.7% agarose gel and were separated by electrophoresis.  Strains were 
compared to a 2-log ladder and to the positive control from RIMD221063 to verify 
approximate gene length.  
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Table 3.1. PCR primers used to screen hemolysin and T3SS associated genes 
Gene Primer 
Amplicon 
size (bp) 
5' - 3' primer sequence Length Tm %GC Reference
L-tl AAAGCGGATTATGCAGAAGCACTG 24 64 46 
tl 
R-tl 
450 
GCTACTTTCTAGCATTTTCTCTGC  24 62 42 
(2) 
L-tdh GTAAAGGTCTCTGACTTTTGGAC 23 61 43 
tdh 
R-tdh 
269 
TGGAATAGAACCTTCATCTTCACC  24 62 42 
(2) 
trh-F4 CTGAATCMCCAGTTAASGC 19 59 50 
trh 
trh-R4 
359 
ATGYCCATTKCCGCTCTC 18 60 55 
(2) 
VP1680-F GTCAAGCTGAGCGCCAC 17 62 64 
vp1680 
VP1680-R 
386 
CACTGATGGCGTATCTTGGTC 21 63 52 
(33) 
VP1686-F TGG CGG CTG CTC AGA AAA ATC CAG A  25 62 52 
vp1686 
VP1686-R 
450 
AAG CCT TCG ATG TGT TGC TTC AAC A  25 59 44 
This study 
YopP-F CAATGTTGGCTATTCGGTTGCAGTCTGTATG 31 62 45 
vpa1346 
YopP-R 
393 
CGTCCAACTCTATTGTTGTGATATGGCGTTG 31 62 45 
(33) 
VPA1362-F GAGCAACCGAACGCATCGC 19 64 63 
vpa1362 
VPA1362-R 
397 
GCAGGTATCGCATCTTCAGC 20 62 55 
(23) 
VP1670-F GCGTCACTGCATTCGACAGG 20 64 60 
vp1670 VP1670-R 338 GACTCGTGTGACTCTGCTG 19 62 57 This study 
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 Following the initial PCR screen to determine the distribution of the T3SS 
effector genes in our clinical and environmental samples, we designed primers to amplify 
a larger region of the genes from the positive strains for nucleotide sequencing.  
Additionally, we added M13 tags to the end of these primers (Table 3.2) so we could 
sequence directly with M13 forward and M13 reverse primers.  Primers for the T3SS 
effector genes were ordered from IDT and a final concentration of 0.5uM of forward and 
reverse primers were combined with 25 ul of 2X iProof High Fidelity GC Master Mix 
(BioRad) for a total reaction volume of 50ul.  The PCR was run in a thermocycler 
according the cycle conditions: initial denaturation at 98°C for 30 seconds, 35 cycles of 
(98°C for 10 seconds, 58°C for 30 seconds, 72°C for 1 minute), and a final elongation at 
72°C for 10 minutes.  The amplicons were applied to gel electrophoresis and the DNA 
was purified from the gel using a Sigma gel extraction kit.  The DNA was quantified with 
a Nanodrop.  We sequenced the genes using an ABI 3134 in the Georgia Institute of 
Technology Genomic Facility.  Cycle sequencing conditions were 95°C for 15 seconds, 
30 cycles of  (95°C for 15 seconds, 55°C for 10 seconds, and 60°C for 4 minutes). 
Forward and reverse sequencing reactions were carried out separately in 10ul reaction 
volumes with 2.5uM forward M13 or 2.5uM reverse M13 primers, 1.75ul of 5X Dilution 
Buffer, 6.75ul DNA template and dH20 mixture with 70ng template, and 0.5ul BigDye 
reaction mix added last to protect from light.  We aligned nucleotide sequences for the 
T3SS1 effectors vp1680, vp1686, and the housekeeping gene recA., determined pairwise 
distances, and constructed phylogenies using MEGA (19). The V. harveyi ATCC BAA-
1116 strain was used as an outgroup for all gene trees.  The V. cholerae 0395 strain, and 
the E. coli K12 M1655 strain were also used as outgroups in the recA tree. 
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Table 3.2. PCR primers used to sequence T3SS effectors. 
Primers 
Amplicon 
size (bp) 5' - 3' primer sequence 
VP1680-FM13 tgtaaaacgacggccagt CAG GCA TCA GCC AAT CCC AAT CTT C 
VP1680-RM13 949 CAGGAAACAGCTATGACCG TCA GTC CGT CAG GCT ACC GAG 
VP1686-FM13 tgtaaaacgacggccagtGCCATCGGTAAAGCCGTGATAACC 
VP1686-RM13 990 CAGGAAACAGCTATGACCGTGAAGGCAAACTCAGCATTGGTGG 
VPA1362-FM13 tgtaaaacgacggccagtGAG CAA CCG AAC GCA TCG CT 
VPA1362-RM13 ~1000 CAGGAAACAGCTATGACCGCGCAGAGAACCAAGAATCTCTGTGG 
VPA1346-FM13 tgtaaaacgacggccagt CGT CCA ACT CTA TTG TTG TGA TAT GGC G 
VPA1346-RM13 750 CAGGAAACAGCTATGACCG GGG CTC TGA TCT TCG TGA ACA G 
 
3.4 Results 
 We collected environmental samples from Skidaway, Georgia and Apalachicola, 
FL in September 2007 and plated the samples on TCBS agar (Figure 3.1A) to separate 
Vibrio parahaemolyticus green colonies and yellow co-occurring Vibrio species.  Figure 
3.1B shows the characteristic blue-green appearance of a pure culture of V. 
parahaemolyticus strain RIMD2210633 on TCBS agar, while Figure 3.1B shows the 
yellow appearance of sucrose fermenting non-V. parahaemolyticus strain Y265.  All of 
the other 39 yellow isolates in this experiment appeared similar to Y265. 
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Figure 3.1. TCBS plates. (A) mixed environmental culture. (B) pure culture of 
RIMD2210633. (C) pure culture of non-V. parahaemolyticus environmental strain Y265. 
 
 PCR templates for all the clinical and environmental strains were obtained as 
described in section 3.3.  PCR results from the hemolysin and T3SS effector screen are 
shown in Figure 3.2.  No PCR amplicons were obtained for tdh or trh within 
environmental isolates that appeared yellow on TCBS (data not shown), but the V. 
parahaemolyticus thermolabile hemolysin gene, tl, was amplified from 19 of these 
isolates. Figure 3.2A shows 10 of these strains.  Additionally, strains SG189 and SG219 
were green on TCBS but were tl negative. The tl results are summarized in Table 3.3 
 PCR results for the T3SS1 apparatus gene vp1670 and effector proteins vp1680 
and vp1686 are shown in Figure 3.2B-E and are summarized in Table 3.3. PCR analyses 
indicated that 22% of environmental isolates that grew yellow on TCBS contain at least 
one T3SS1 or T3SS2 effector gene, while 11% of these presumptive non-V. 
parahaemolyticus isolates contain at least two effector genes from either T3SS1, T3SS2, 
or both (Table 3.5).  Clinical isolates showed a greater frequency for the vp1680 and 
vpa1362 effectors but a lower frequency for vp1686 and vpa1362 than Vibrio 
parahaemolyticus environmental isolates (Table 3.4).  Environmental isolates that grew 
yellow on TCBS had fewer effector genes than all V. parahaemolyticus clinical and 
environmental isolates examined (Table 3.4). 
C
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 New primers were designed to amplify approximately 1kb of the effector genes 
for sequencing, as described in section 3.3, from V. parahaemolyticus clinical isolates, 
environmental isolates, and the yellow TCBS strains that were determined to contain the 
genes shown in Table 3.3.  Effector genes were amplified and gel extracted from clinical 
isolates and environmental V. parahaemolyticus isolates, but few 1kb effector genes from 
the yellow TCBS strains with could be amplified. Most of the amplicons from the yellow 
TCBS isolates were in such low yield that they could not be sequenced.  For example, 
vp1680 and vp1686 were both amplified from Y169 (Figure 3.3) in duplicate to increase 
the DNA concentration following gel extraction, but we did not obtain sequences for 
these genes.  Furthermore, while the initial PCR confirmed that Y128 was positive for 
both vp1680 and vp1686, the vp1686 effector gene from Y128 (Figure 3.6) was the only 
effector that we managed to obtain a sequence for from all the strains listed in Table 3.3.  
 Nucleotide sequences for vp1680, vp1686, and recA were aligned, as described in 
section 3.3, from V. parahaemolyticus clinical and environmental strains.  In addition, 
vp1686 and recA were sequenced from Y128. A segment of the vp1680 alignment is  
shown in Figure 3.4 and a segment of the vp1686 alignment is shown in Figure 3.7. 
Pairwise gene differences showed that all vp1680 and vp1686 environmental sequences 
were at least 97% identical to the published nucleotide sequences from RIMD2210633. 
The vp1680 effector gene from the V. parahaemolyticus AF91 was 99% identical to 
vp1680 from RIMD2210633. Gene trees are shown for vp1680 in Figure 3.5, for vp1686 
in Figure 3.8, and for recA in Figure 3.9.  All of the recA sequences from the 
environmental isolates are more closely related to the recA sequence from the ATCC 
BAA-1116 strain of V. harveyi than to V. cholerae strain O395.  The recA tree also shows 
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that the V. parahaemolyticus strain AF91 groups with RIMD2210633 in the O3:K6 clade. 
Additionally, vp1680 from AF91 appears to be closely related to the vp1680 from 
RIMD2210633.  
 
Figure 3.2. tl and T3SS1 genes from yellow environmental strains. tl is 450bp and 
vp1680 is 386 bp. vp1670 is 338bp (A) tl+ strains. Lane 1 is the 2-log ladder and lane 2 is 
RIMD2210633. Lanes 3- 12 are strains Y97, Y106, Y110, Y117, Y128, Y136, Y137, 
Y150, Y157, Y169, Y172, Y174, Y186, Y193, and Y203. (B) and (C) are vp1680 
amplicons. In (B), Lane 1 is the 2-log ladder and lanes 1 and 2 are duplicates of the 
vp1680 from RIMD2210633. The following lanes are representative samples of the 
environmental strains that appeared yellow on TCBS. The strain Y169 is positive. (C) is 
another representative sample of vp1680. RIMD2210633 is shown in lane 2. Y217 is 
positive. (D) and (E) are representative samples of vp1670 from various environmental 
isolates that grew yellow on TCBS. RIMD2210633 is shown in lane 2 for both gels. In 
(D), Y128 and Y169 are positive for vp1670, and Y172 and Y193 are shown to be 
positive for vp1670 in (E). 
 
A
B C 
D
 
E 
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Table 3.3.  T3SS1 and T3SS2 apparatus and effector gene distribution for presumptive 
non - Vibrio parahaemolyticus strains.  
Non-Vp 
environmental tl vp1670 vp1680 vp1686 vpa1354 vpa1346 vpa1362 
Y1 - - - - - - - 
Y3 - - - - - - - 
Y12 - - - - - - - 
Y17 + - - - - - - 
Y26 + - - - - - - 
Y36 - - - - - - - 
Y44 - - - - - - - 
Y54 - - - - - - - 
Y63 - - - - - - - 
Y89 - - - - - - - 
Y97 + - - - ? - + 
Y106 + - - - - - - 
Y110 + - - - - - - 
Y117 + - - - - - - 
Y128 + + + + - - + 
Y136 + - - - - - - 
Y137 + - - - - - - 
Y150 + - - - - - - 
Y157 + - - - - - - 
Y169 + + + + - - - 
Y172 + + - + - - - 
Y174 + - - - - - - 
Y186 + - - - - - - 
Y193 + + - - - - - 
Y203 + - - - - - - 
Y207 - - - - - - - 
Y216 - - - - - - - 
Y217 - ? + - - - - 
Y220 - - - - - - - 
Y224 - - - - - - - 
Y231 - - - - - - - 
Y234 - - - - - - - 
Y239 - - - - - - - 
Y249 + - - - - - + 
Y256 + - - - - - - 
Y265 - - - - - - - 
Y275 - - - - - - - 
Y285 - - - - - - - 
Y290 - - - - - - - 
Y297 - - - - - - - 
        
SG189 -   - +   - + 
SG219 -   + +   - - 
SG395 -   - -   + + 
SG291 -   - +   - - 
* All strains shown are presumptive non-Vibrio parahaemolyticus strains shown due to 
either yellow growth on TCBS or absence of tl. The prefix Y indicates yellow growth on 
TCBS medium. Highlighted strains contain at least one T3SS effector.  Strains with 
borders on the left are either yellow strains with the V. parahaemolyticus hemolysin tl 
gene or tl- strains that appear green on TCBS.  
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Table 3.4.  T3SS effector distribution among environmental Vibrio spp. and V. 
parahaemolyticus clinical isolates.  
 
 (frequency) 
 T3SS1 effectors T3SS2 effectors 
Source VP1680 VP1686 VPA1346 VPA1362 
Vp clinical  
(n = 26) (96.2) 25 (65.4) 17 (15.4) 4 (88.5) 23 
Vp environmental 
(n = 37) (91.9) 34 (83.8) 31 (27.0) 10 (64.9) 24 
Yellow colonies 
(non-Vp, n = 46) (6.5) 3 (13.0) 6 (2.2) 1 (10.9) 5 
 
* Vp clinical strains isolated from patients include RIM2210633 and 25 V. 
parahaemolyticus strains from the CDC.  T3SS1 effector genes vp1680, vp1686, and 
T3SS2 effector genes vpa1346 and vpa1362, were identified using a PCR screen using 
primers previously developed (11). 
 
 
Table 3.5. Percent of non- V. parahaemolyticus strains with two effector genes. 
Virulence genes Strains Percent 
Non-Vp T3SS1 effectors vp1680+ and vp1686+ Y169, SG219 4.3%  
Non-Vp T3SS2 effector vpa1346+ and vp1362+ 
strains  SG395 2.2%  
Non-Vp mixed T3SS effectors Y128, SG189 4.3%  
 
*Mixed T3SS effectors are strains positive for either vp1680 or vp1686 and also positive 
for either vpa1346 or vpa1362. 
 
 
Figure 3.3.  PCR amplification of vp1680 and vp1686. Top 949-bp vp1680 from Y169 
and bottom 990-bp vp1686 genes from Y169. Reactions were duplicated to increase the 
amplicons’ DNA concentrations. 
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Figure 3.4.  Partial alignment of the vp1680. Nucleotide sequences are from Vibrio 
parahaemolyticus clinical and environmental strains. The alignment was generated in 
MEGA (19) using ClustalW. 
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Figure 3.5. vp1680 phylogeny. A neighbor-joining tree of vp1680 gene sequence 
constructed with the kimura 2-parameter model in MEGA 3 with 1,000 bootstrap 
replications.  Values shown are ≥50.  The outgroup is a hypothetical protein-encoding 
gene from V. harveyi. 
 
 
Figure 3.6. vp1686 amplicon (990-bp) from Y128. 
VP1686 E
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Figure 3.7.  Partial alignment of vp1686. Nucleotide sequences are from V. 
parahaemolyticus clinical and environmental strains that were green on TCBS with the 
exception of Y128, which was yellow on TCBS. The alignment was generated in MEGA 
(19) using ClustalW. 
 
 
Figure 3.8.  vp1686 phylogeny. A neighbor-joining tree of vp1686 gene sequence 
constructed with the kimura 2-parameter model in MEGA 3 with 1,000 bootstrap 
replications.  Values shown are ≥50.  The outgroup is a V. harveyi hypothetical protein-
encoding gene. 
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Figure 3.9.  recA phylogeny. Neighbor-joining tree of recA housekeeping gene 
sequences constructed with the kimura 2-parameter model in MEGA (19) with 1000 
bootstrap replications. Values ≥50 are shown. Outgroups include V. harveyi, V. cholerae, 
and E. coli. 
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3.5 Discussion 
 Our data shows that 22% of non- Vibrio parahaemolyticus environmental isolates 
contain at least one T3SS1 or one T3SS2 effector gene (Table 3.4), while 11% contain 
two T3SS1 effector genes, two T3SS2 effector genes, or one effector gene from each 
gene cluster (Table 3.5).  These percentages may be overestimates considering several of 
the yellow isolates were actually tl+ (Table 3.3).  Since the presence of tl is often used to 
identify V. parahaemolyticus, this indicates that either the commonly used TCBS screen 
is not discriminatory enough to identify Vibrio species or that some V. parahaemolyticus 
strains may have acquired the ability to ferment sucrose.  Alternately, the tl gene itself 
may have undergone LGT from a V. parahaemolyticus strain to another Vibrio spp. Since 
housekeeping genes are conserved among species, analyzing their nucleotide sequences 
for mutations is useful for identifying species. Species are more closely related if their 
housekeeping genes are more similar.  Sequencing of recA is ongoing to determine 
whether these strains are V. parahaemolyticus or another Vibrio spp.  Because the 
phylogeny for recA shows that the recA sequence from Y128 groups with the V. 
parahaemolyticus recA sequences instead of one of the outgroups (Figure 3.9), we expect 
that Y128 is a strain of V. parahaemolyticus that can ferment sucrose.  Sequencing of tl 
amplicons is ongoing to determine whether the gene is undergoing LGT, or if V. 
parahaemolyticus isolates have actually acquired the ability to ferment sucrose.  If this 
strain has acquired the ability to ferment sucrose, then more microbiological plating or 
biochemical reactions may be necessary to identify V. parahaemolyticus from other 
species of bacteria.  Due to difficulties with TCBS, one study shows that a more complex 
and time consuming two step enrichment technique with the non-selective Tripticase Soy 
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Broth, followed by a selective salt polymixin broth, and chromogenic agar plating will 
display violet colonies as V. parahaemolyticus due to a beta galactisidase substrate (13).  
In this method, violet colonies are more easily detected as compared to green colonies on 
TCBS.   
 Interestingly, Figure 3.9 shows that V. parahaemolyticus environmental isolates 
appear to be more closely related to the ATCC BAA-1116 strain of V. harveyi than to the 
V. cholerae strain O395 based on recA sequences.  Although this may be expected for a 
housekeeping gene, prior research has shown that non-01 and non-0139 strains of V. 
cholerae contain the V. parahaemolyticus T3SS2 gene cluster (9).  Sequencing is ongoing 
for the T3SS2 translocator gene vpa1354 and T3SS2 effectors vpa1346 and vpa1362 
from environmental isolates to examine their similarity to the RIMD2210633 genes.  If 
the recA sequences of the environmental strains group with V. harveyi but the T3SS2 
translocator and effector genes group with V. cholerae, then LGT of the T3SS2 loci may 
be occurring.  However, select housekeeping genes should be analyzed prior to 
examining the diversity of the T3SS2 effector sequences in case the strains that grew 
yellow on TCBS are identified as sucrose fermenting Vibrio parahaemolyticus isolates. 
 The gene trees for both vp1680 (Figure 3.5) and recA (Figure 3.9) show that the 
environmental V. parahaemolyticus strain AF91 grouped within the O3:K6 pandemic 
serotype, which indicates that we may have isolated a pandemic strain from sediment 
collected in FL.  More housekeeping genes must be sequenced from this strain to be 
certain that it is related to the clonal pandemic strain.  Also, the environmental V. 
parahaemolyticus isolate 22702 is closely related to the O3:K6 serogroup based on recA 
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analysis alone (Figure 3.9); however, sequence analysis of other housekeeping genes 
indicates 22702 is not related to the O3:K6 strains.  
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CHAPTER 4 
CONCLUSION 
 
 
 In conclusion, we have evidence that the pandemic O3:K6 bacteriocin gene 
vpa1263 is distributed among environmental V. parahaemolyticus isolates.  Furthermore, 
we have shown that the RIMD2210633 strain produces the bacteriocin on fine-texture 
agar.  Bacteriocin screens are ongoing to determine whether the environmental isolates 
that contain the gene can produce a functional bacteriocin.  Expression analysis with RT-
PCR during the varying stages of growth could provide insight into the circumstances 
surrounding bacteriocin production.   
 While we have evidence for the distribution of T3SS effector genes within strains 
that grow yellow on TCBS, we cannot definitively state that LGT is occurring for these 
genes because the TCBS screening technique may not be discriminatory enough to 
identify V. parahaemolyticus.  This is because both vp1686 and the recA sequences for 
one of the strains that grew yellow on TCBS suggest that the bacterium is actually a V. 
parahaemolyticus that can ferment sucrose.  Because the result may still be due to LGT 
of the tl, we plan to continue sequencing housekeeping genes and start sequencing tl.  
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